NCT06085560

Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening

Enrolling by Invitation
NAAges 45–72InterventionalScreening
Michigan State University
~600 participants
Updated 2026-05-08 on ClinicalTrials.gov
What's tested:Usual Care MessageImplementation Intention Intervention: Standard MessageImplementation Intention Intervention: Culturally-Targeted Message

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Colorectal Cancer Screening Modality Request Rates
Measured over up to 2 weeks
+3 more outcomes measured
Colorectal Cancer
1 sites across 1 states
Michigan1

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

African American, ages 45-72, Medicaid or Medicare or private insurance, current health center patient, eligible for CRC screening (Colonoscopy more than 10 years ago, Sigmoidoscopy more than 5 years ago, FOB test more than 1 year ago, FIT kit more than 1 year ago, sDNA test more than 3 years ago, Never been screened).
  • Colorectal Cancer Screening Modality Request Ratesup to 2 weeks

    Frequency (percentage) with which colonoscopy versus FIT Kit versus sDNA kit versus no screening are selected.

  • Colorectal Cancer Screening Completion Rateup to 6 months

    Frequency (percentage of time) that chosen screening method is fully completed.

  • Theory of Planned Behavior Colorectal Cancer Screening Outcomescollected immediately, up to 1 hour

    Self-report measures of colorectal cancer screening attitudes, norms, perceived control, intentions to be screened are each adapted from published research (Lucas et al., 2021). These items are constructed following recommended procedures to ensure construct validity and adequate behavioral specificity (Fishbein \& Ajzen, 2011). All items use Likert-type scales that range from 1 (strongly agree) to 7 (strongly disagree).

  • Anticipatory Racismcollected immediately, up to 1 hour

    Adapted from published research (Lucas et al., 2021), all participants respond to questions that asked whether they believe racism would impact the benefits they could experience from obtaining colorectal cancer screening. Participants will then respond to three questions that ask, "In some way, my obtaining CRC screening would be impacted by racism," "Racism would undermine the value of CRC screening for me." and "Racism would negatively impact the accuracy of my CRC screening. Responses are collected using a 7-point Likert-type scale that ranged from 1 (strongly agree) to 7 (strongly disagree).